Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis (Q41150051)

27 September 2017

Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

27 September 2017

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537011%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

E Barba

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537011%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

G Girolomoni

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537011%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

4 November 2015

1 reference

Journal of the European Academy of Dermatology and Venereology

27 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537011%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537011%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

282-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537011%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537011%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis and clinical features of psoriasis

6 June 2020

cites work

1 reference

Psoriasis patients show signs of insulin resistance

21 January 2018

1 reference

The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic

21 January 2018

1 reference

Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

21 January 2018

1 reference

Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study

21 January 2018

1 reference

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease and the metabolic syndrome

21 January 2018

1 reference

Fatty liver: a novel component of the metabolic syndrome

21 January 2018

1 reference

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a review of current understanding and future impact

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Noninvasive evaluation of NAFLD.

21 January 2018

1 reference

Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

21 January 2018

1 reference

Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity

21 January 2018

1 reference

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

21 January 2018

1 reference

Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment

21 January 2018

1 reference

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.

21 January 2018

1 reference

Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.

21 January 2018

1 reference

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

21 January 2018

1 reference

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

21 January 2018

1 reference

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

21 January 2018

1 reference

A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.

21 January 2018

1 reference

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials?

21 January 2018

1 reference

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JDV.13456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26537011%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference